Opinion & analysis

Immuno-Oncology: Unicorns, China And The Perfect Storm

Immuo-oncology is proving to be that rare animal for investors in pharma, where return on invested capital doesn’t seem necessarily tied to risk, with mature assets returning liquidity similar to those of early assets. Examine transaction trends, investor activity, and the exit landscape for this important area.

Immuno-Oncology: Unicorns, China And The Perfect Storm

Unilever Seeks End To Litigation Over St. Ives Scrub, Plaintiffs’ ‘Fake Medical Condition’

Nail Polishes Contain Undeclared DEHP, Among Other ‘Regrettable Substitutions’ – Study

FDA Ban On Flavoring Ingredients Should Prompt Removal From Fragrances – WVE

What Do Cosmetics Reform Campaigners Dream Of At Night? Rep. Schakowsky Just Reintroduced It

DECIEM, Truly ‘The Abnormal Beauty Company,’ Faces Uncertain Future

Real-World Evidence: US FDA’s Prucalopride Review Shows Datasets’ Utility And Limitations

Drug/Software Combo Platform Coming Soon To US FDA, Gottlieb Says

Biosimilar Suffixes Appear Superfluous In Adverse Event Reporting

Adaptive Clinical Trial Designs: US FDA Provides Checklist To Begin Study

OTC Distribution in Europe – The New Global Agenda

Philips To Create More Context, Connectedness And Continuity And Shift Sick Care To Health Care

Game On For Akili’s Cognitive Control Tech

Engaging Patients and Navigating Laws: What To Consider When Developing Health Apps

Telehealth, Wearables and Apps – Report 3

Telehealth, Wearables and Apps – Report 2

Telehealth, Wearables and Apps – Report 1

Special Report: The Intersection Between Tech and Pharma (Part 1. Google)

Pharma Intelligence Report Store Article Collection Innovation, Data and Machine Learning Report 2

Pharma Intelligence Report Store Article Collection Digital Policy & Regulation Report 2

Pharma Intelligence Report Store Article Collection Digital Policy & Regulation Report 1

Pharma Intelligence Report Store Article Collection Digital Patient Management

Pharma Intelligence Report Store Article Collection Innovation, Data and Machine Learning Report 1

Pharma Intelligence Report Store Article: Collection Cybersecurity

Transforming Pharmaceutical R&D with Data

Data in Healthcare: Underpinning the Shift to Value

Wearables are Transforming R&D and Care Delivery

The Intersection Between Tech and Pharma Special Report (Part 3. Intel, Samsung, IBM, and GE)

The Intersection Between Tech and Pharma Special Report (Part 2. Apple)